Paying the price for cure-treating cancer survivors with growth hormone.

作者信息

Sklar C

机构信息

Long-Term Follow-Up Program, Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA.

出版信息

J Clin Endocrinol Metab. 2000 Dec;85(12):4441-3. doi: 10.1210/jcem.85.12.7152.

DOI:10.1210/jcem.85.12.7152

PMID:11134090

Abstract

摘要

相似文献

Paying the price for cure-treating cancer survivors with growth hormone.

J Clin Endocrinol Metab. 2000 Dec;85(12):4441-3. doi: 10.1210/jcem.85.12.7152.

Growth hormone therapy does not induce cancer.

Nat Clin Pract Endocrinol Metab. 2006 Oct;2(10):532-3. doi: 10.1038/ncpendmet0294.

Safety of growth hormone treatment in patients previously treated for cancer.

Endocrinol Metab Clin North Am. 2012 Dec;41(4):785-92. doi: 10.1016/j.ecl.2012.07.002. Epub 2012 Sep 13.

Does growth hormone therapy increase the risk of cancer?

Nat Clin Pract Endocrinol Metab. 2006 Oct;2(10):530-1. doi: 10.1038/ncpendmet0295.

Growth hormone treatment of children with brain tumors and risk of tumor recurrence.

J Clin Endocrinol Metab. 2000 Dec;85(12):4444-9. doi: 10.1210/jcem.85.12.7044.

Rapid enlargement of a residual craniopharyngioma during short-term growth hormone replacement.

Childs Nerv Syst. 2002 Nov;18(11):565; author reply 566. doi: 10.1007/s00381-002-0647-3. Epub 2002 Sep 12.

Growth hormone treatment: cancer risk.

Horm Res. 2004;62 Suppl 3:30-4. doi: 10.1159/000080496.

Growth hormone treatment and cancer risk.

Endocrinol Metab Clin North Am. 2007 Mar;36(1):247-63. doi: 10.1016/j.ecl.2006.11.007.

Changes in the volume of residual pituitary adenomas in patients with adult-onset growth hormone deficiency during replacement therapy with the recombinant human growth hormone.

Wien Klin Wochenschr. 1999 Nov 12;111(21):887-90.

Does growth hormone increase the risk of malignancies?

Horm Res. 1993;39(3-4):99-101. doi: 10.1159/000182705.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Paying the price for cure-treating cancer survivors with growth hormone.

J Clin Endocrinol Metab. 2000 Dec;85(12):4441-3. doi: 10.1210/jcem.85.12.7152.

Growth hormone therapy does not induce cancer.

Nat Clin Pract Endocrinol Metab. 2006 Oct;2(10):532-3. doi: 10.1038/ncpendmet0294.

Safety of growth hormone treatment in patients previously treated for cancer.

Endocrinol Metab Clin North Am. 2012 Dec;41(4):785-92. doi: 10.1016/j.ecl.2012.07.002. Epub 2012 Sep 13.

Does growth hormone therapy increase the risk of cancer?

Nat Clin Pract Endocrinol Metab. 2006 Oct;2(10):530-1. doi: 10.1038/ncpendmet0295.

Growth hormone treatment of children with brain tumors and risk of tumor recurrence.

J Clin Endocrinol Metab. 2000 Dec;85(12):4444-9. doi: 10.1210/jcem.85.12.7044.

Rapid enlargement of a residual craniopharyngioma during short-term growth hormone replacement.

Childs Nerv Syst. 2002 Nov;18(11):565; author reply 566. doi: 10.1007/s00381-002-0647-3. Epub 2002 Sep 12.

Growth hormone treatment: cancer risk.

Horm Res. 2004;62 Suppl 3:30-4. doi: 10.1159/000080496.

Growth hormone treatment and cancer risk.

Endocrinol Metab Clin North Am. 2007 Mar;36(1):247-63. doi: 10.1016/j.ecl.2006.11.007.

Changes in the volume of residual pituitary adenomas in patients with adult-onset growth hormone deficiency during replacement therapy with the recombinant human growth hormone.

Wien Klin Wochenschr. 1999 Nov 12;111(21):887-90.

Does growth hormone increase the risk of malignancies?

Horm Res. 1993;39(3-4):99-101. doi: 10.1159/000182705.